|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Non-hormonal methods of contraception in diabetic women: reliability, risks, |
| precautions, follow-up. [Methodes non hormonales de contraception chez les |
| femmes diabetiques: fiabilite, risques, precautions, surveillance.] |
| Journees Annuelles de Diabetologie de L Hotel-Dieu. 1983 May 5-7;:239-52. |
| Their lack of secondary effects on glucose metabolism, lipids, and coagulation factors make nonhormonal |
| contraceptive methods appropriate for diabetic women. The effectiveness and risks of nonhormonal contraceptive |
| methods in diabetic women are however not well known because of the lack of relevant studies. IUDs were until |
| recently regarded as a good method for diabetic women because of their effectiveness, absence of effects on ovarian |
| function, reversibility, lack of metabolic repercussions, and ease of use. A 1980 publication which reported 11 |
| pregnancies among 30 diabetic women using IUDs prompted a review of the subject and a search for possible |
| factors responsible for the elevated failure rate. Copper IUDs, currently the most widely used, are lighter than inert |
| devices and are of various forms. Like other IUDs, they function by reducing chances of fertilization, preventing |
| implantation, and perhaps favoring destruction of the ovum. Factors in failure of IUDs include defective placement, |
| the most common; secondary displacement and expulsion; alterations to the IUD in the uterus; or possibly the |
| influence of some drugs such as antiprostaglandins. Other studies failed to disclose a higher rate of IUD failure |
| among diabetics, and the 1980 study that did so was criticized for inappropriate controls, insufficient documentation, |
| and failure to specify follow-up or surveillance of the patients. It is possible that the rate of expulsion is higher in |
| diabetic women but this hypothesis is not yet proven. Diabetes does not seem to be associated with a spectacular |
| increase in incidence of salpingitis in IUD users, but the consequences of an infection on the disease and for later |
| fertility justify vigilance in patient follow-up. No case of ectopic IUD was reported in 3 studies of IUD use by |
| diabetics, and the IUD does not seem to be associated with an elevated incidence of bleeding or pain. At present |
| there is no reason to modify the rules commonly in use for IUDs among other women specifically for diabetics, but |
| contraindications and other precautions must be scrupulously observed. All diabetic multiparas without known |
| antecedents of salpingitis can benefit from IUD use, but use should be discouraged in nulliparous diabetics. The |
| goals of surveillance include decreasing the risks of defective placement, displacement, and complications. |
| Diaphragms, vaginal spermicides, and condoms are free of metabolic effects but less effective than IUDs. Natural |
| methods should be discouraged in diabetic women because of their lower efficacy. (PubHealth.info Document ID: |
| PubHealth.info NOTE: The author(s) of this article titled, "Non-hormonal methods of contraception in diabetic |
| women: reliability, risks, precautions, follow-up. [Methodes non hormonales de contraception chez les femmes |
| diabetiques: fiabilite, risques, precautions, surveillance.]", is(are) Buchsenschutz D. The source of this article is |
| "Journees Annuelles de Diabetologie de L Hotel-Dieu. 1983 May 5-7;:239-52.". This article was published in 1983 in |
| French language(s). (PubHealth.info® Document ID: CONT5T 2040-06. All rights reserved with PubHealth.info) PIN: |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |